CEO Position At JH Medicine Approved Trustees of both the university and the Johns Hopkins Health System have approved a proposal to create a new position of chief executive officer of Johns Hopkins Medicine. The boards of trustees, at separate meetings last week, also agreed to greatly expand the board of Johns Hopkins Medicine and to formally delegate some of their authority to that board. They also created a smaller operating committee of the Johns Hopkins Medicine board, to be headed by the president of the university. Health system board chair George L. Bunting Jr. and university board chair Morris W. Offit said the decisions will result in closer integration of the university's School of Medicine and the health system's two hospitals and other patient care subsidiaries. "This new structure will formalize changes in governance that have been evolving over the past year and allow us to speak and act as one in our responses to the current revolution in health care delivery, while remaining true to our missions of research, teaching and patient care," Bunting and Offit wrote in a memo last week to all Johns Hopkins Medicine employees. Though the university and health system have been separate corporations since their creation, they have always worked closely together. They created the joint organizational structure called Johns Hopkins Medicine last year in recognition that even closer cooperation was necessary in the rapidly changing health care environment. The new chief executive officer will report to the president of the university--currently interim president Daniel Nathans--in his capacity as chair of the operating committee of the Johns Hopkins Medicine board. In turn, the president of the health system and the dean of the medical school will report to the new CEO. The full board of Johns Hopkins Medicine, which now has 10 voting members, will expand to about 40, a third from the university board, a third from the health system board and a third from members who serve on both. The operating committee will have 15 members, chosen in the same proportions, with the university president as chair and 16th member. The new CEO will be appointed by the full board of Johns Hopkins Medicine, on the recommendation of the university president in conjunction with a search committee headed by Johns Hopkins Medicine trustee Edward K. Dunn Jr.